RWJ-110192

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameRWJ-110192
Drug Alias NameRWJ-110192
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitors
TargetsUDP-N-acetylglucosamine 1-carboxyvinyltransferase
Therapy Area/IndicationsBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesJohnson & Johnson
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesJohnson & Johnson
Active IndicationsN/A
Inactive IndicationsBacterial Infections

Other Information

ATC CodeN/A
Related LinksN/A